» Articles » PMID: 31481962

Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells

Abstract

Indoleamine 2,3-dioxygenase 1 (IDO1) catalyzes the first step in the kynurenine pathway of tryptophan (Trp) degradation that produces several biologically active Trp metabolites. L-kynurenine (Kyn), the first byproduct by IDO1, promotes immunoregulatory effects via activation of the Aryl hydrocarbon Receptor (AhR) in dendritic cells (DCs) and T lymphocytes. We here identified the nuclear coactivator 7 (NCOA7) as a molecular target of 3-hydroxyanthranilic acid (3-HAA), a Trp metabolite produced downstream of Kyn along the kynurenine pathway. In cells overexpressing NCOA7 and AhR, the presence of 3-HAA increased the association of the two molecules and enhanced Kyn-driven, AhR-dependent gene transcription. Physiologically, conventional (cDCs) but not plasmacytoid DCs or other immune cells expressed high levels of NCOA7. In cocultures of CD4 T cells with cDCs, the co-addition of Kyn and 3-HAA significantly increased the induction of Foxp3 regulatory T cells and the production of immunosuppressive transforming growth factor β in an NCOA7-dependent fashion. Thus, the co-presence of NCOA7 and the Trp metabolite 3-HAA can selectively enhance the activation of ubiquitary AhR in cDCs and consequent immunoregulatory effects. Because NCOA7 is often overexpressed and/or mutated in tumor microenvironments, our current data may provide evidence for a new immune check-point mechanism based on Trp metabolism and AhR.

Citing Articles

Aromatic Amino Acid Metabolites: Molecular Messengers Bridging Immune-Microbiota Communication.

Shin H, Bang Y Immune Netw. 2025; 25(1):e10.

PMID: 40078785 PMC: 11896664. DOI: 10.4110/in.2025.25.e10.


Modulation of the thiol redox proteome by sugarcane ash-derived silica nanoparticles: insights into chronic kidney disease of unknown etiology.

Stem A, Michel C, Harris P, Rogers K, Gibb M, Roncal-Jimenez C Part Fibre Toxicol. 2025; 22(1):3.

PMID: 39910563 PMC: 11800628. DOI: 10.1186/s12989-025-00619-8.


Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy.

Huang K, Han Y, Chen Y, Shen H, Zeng S, Cai C Mol Cancer. 2025; 24(1):7.

PMID: 39789606 PMC: 11716519. DOI: 10.1186/s12943-024-02205-6.


Crosstalk between macrophages and immunometabolism and their potential roles in tissue repair and regeneration.

Ma H, Gao L, Chang R, Zhai L, Zhao Y Heliyon. 2024; 10(18):e38018.

PMID: 39381218 PMC: 11458987. DOI: 10.1016/j.heliyon.2024.e38018.


The Roles of Gut Microbiota Metabolites in the Occurrence and Development of Colorectal Cancer: Multiple Insights for Potential Clinical Applications.

Cheng W, Li F, Yang R Gastro Hep Adv. 2024; 3(6):855-870.

PMID: 39280926 PMC: 11401567. DOI: 10.1016/j.gastha.2024.05.012.


References
1.
Nguyen T, Hoivik D, Lee J, Safe S . Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex. Arch Biochem Biophys. 1999; 367(2):250-7. DOI: 10.1006/abbi.1999.1282. View

2.
Lee J, Lee Y, Na S, Jung D, Lee S . Transcriptional coregulators of the nuclear receptor superfamily: coactivators and corepressors. Cell Mol Life Sci. 2001; 58(2):289-97. PMC: 11146491. DOI: 10.1007/PL00000856. View

3.
Liu Y . Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell. 2001; 106(3):259-62. DOI: 10.1016/s0092-8674(01)00456-1. View

4.
Chawla A, REPA J, Evans R, Mangelsdorf D . Nuclear receptors and lipid physiology: opening the X-files. Science. 2001; 294(5548):1866-70. DOI: 10.1126/science.294.5548.1866. View

5.
McKenna N, OMalley B . Combinatorial control of gene expression by nuclear receptors and coregulators. Cell. 2002; 108(4):465-74. DOI: 10.1016/s0092-8674(02)00641-4. View